Interobserver variability for the WHO classification of pulmonary carcinoids

Dorian R A Swarts1, Robert-Jan van Suylen, Michael A den Bakker

  • 1Departments of *Molecular Cell Biology #Pulmonology ∥∥Pathology, GROW - School for Oncology & Developmental Biology, Maastricht University Medical Center, Maastricht **Department of Surgery, Máxima Medical Center, Veldhoven, The Netherlands; CARIM - School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, The Netherlands †Departments of Pathology, Jeroen Bosch Hospital, 's-Hertogenbosch ‡Maasstad Hospital, Rotterdam §Sint Antonius Hospital, Nieuwegein ∥VU University Medical Center, Amsterdam ††Departments of Pulmonology, Atrium Medical Center, Heerlen ‡‡Viecuri Medical Center, Venlo §§Catharina Hospital, Eindhoven, The Netherlands ¶Department of Oncology, Division of Pathology, University of Turin at San Luigi Hospital, Orbassano, Turin, Italy.

Summary

Histopathologic classification of lung carcinoids shows significant interobserver variation, especially for atypical carcinoids. Immunomarkers like Ki-67 can improve diagnostic accuracy and prognostic prediction.